Evidence map›Paper›PMID 42912130›Full record

ArticleMemorias do Instituto Oswaldo Cruz2026

Can Hantavirus cruise into the next pandemic?

Nias Yg Peng, Alejandro Rojas-Fernandez, Joshua M Deerain, Julio Aguado, Marcio Rt Nunes, Alberto A Amarilla

Abstract read
In one paragraph

Article in Memorias do Instituto Oswaldo Cruz, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nias Yg PengNo current affiliation - Previously Commonwealth Scientific and Industrial Research Organization, Health & Biosecurity, Black Mountain, Canberra, Australia.ORCID https://orcid.org/0000-0002-7488-5441
Alejandro Rojas-FernandezUniversidad Austral de Chile, Faculty of Medicine, Institute of Medicine, Valdivia, Chile.
Joshua M DeerainCommonwealth Scientific and Industrial Research Organization, Australian Centre for Disease Preparedness, East Geelong, Australia.
Julio AguadoUniversity of Colorado, Department of Pharmaceutical Sciences, Aurora, Colorado, USA.
Marcio Rt NunesUniversidade Federal do Pará, Instituto de Ciências Biológicas, Laboratório de Tecnologia Biomolecular, Belém, PA, Brasil.
Alberto A AmarillaCommonwealth Scientific and Industrial Research Organization, Australian Centre for Disease Preparedness, East Geelong, Australia.ORCID https://orcid.org/0000-0002-6640-3377

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite concerns arising from a recent ship-associated outbreak on the M/V Hondius cruise, current evidence suggests that Andes virus (ANDV) poses a low pandemic risk. Nevertheless, viral evolution, ecological changes, and reservoir host dynamics could drive future emergence of ANDV, underscoring the need for improved surveillance, diagnostics, therapeutics, and vaccine preparedness.

Indexed as

Hantavirus InfectionsOrthohantavirusPandemicsShipsAnimalsHumans

Identifiers

PMID42912130
PMCPMC13679879

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.